Xenon Pharmaceuticals Inc (XENE)
43.35
+1.65
(+3.96%)
USD |
NASDAQ |
Nov 05, 16:00
43.35
0.00 (0.00%)
After-Hours: 18:51
Xenon Pharmaceuticals Price: 43.35 for Nov. 5, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 04, 2024 | 41.58 | 42.44 | 41.29 | 41.70 | 405992.0 |
| Nov 01, 2024 | 41.46 | 41.69 | 40.66 | 41.69 | 291442.0 |
| Oct 31, 2024 | 41.64 | 42.34 | 40.79 | 41.11 | 332681.0 |
| Oct 30, 2024 | 41.43 | 42.35 | 41.43 | 41.89 | 224577.0 |
| Oct 29, 2024 | 41.87 | 42.04 | 41.26 | 41.78 | 327139.0 |
| Oct 28, 2024 | 42.03 | 42.24 | 41.59 | 41.74 | 416344.0 |
| Oct 25, 2024 | 41.90 | 42.59 | 41.17 | 41.73 | 379591.0 |
| Oct 24, 2024 | 42.05 | 42.66 | 41.66 | 41.85 | 526013.0 |
| Oct 23, 2024 | 42.62 | 42.66 | 41.22 | 41.66 | 280123.0 |
| Oct 22, 2024 | 43.74 | 43.96 | 42.49 | 42.74 | 393521.0 |
| Oct 21, 2024 | 44.45 | 44.84 | 43.64 | 44.21 | 438746.0 |
| Oct 18, 2024 | 43.38 | 45.52 | 43.05 | 44.86 | 483385.0 |
| Oct 17, 2024 | 42.62 | 43.98 | 42.22 | 43.31 | 471728.0 |
| Oct 16, 2024 | 40.90 | 42.63 | 40.73 | 42.62 | 304331.0 |
| Oct 15, 2024 | 41.75 | 41.98 | 40.46 | 40.71 | 167938.0 |
| Oct 14, 2024 | 41.53 | 41.79 | 41.02 | 41.76 | 226017.0 |
| Oct 11, 2024 | 40.29 | 41.68 | 40.17 | 41.21 | 349635.0 |
| Oct 10, 2024 | 39.58 | 40.48 | 39.23 | 40.41 | 280964.0 |
| Oct 09, 2024 | 41.05 | 41.25 | 39.37 | 39.42 | 677506.0 |
| Oct 08, 2024 | 40.67 | 41.48 | 40.05 | 41.02 | 402762.0 |
| Oct 07, 2024 | 41.00 | 41.08 | 40.18 | 40.59 | 324910.0 |
| Oct 04, 2024 | 39.81 | 41.38 | 39.77 | 40.73 | 182849.0 |
| Oct 03, 2024 | 40.65 | 41.12 | 39.27 | 39.70 | 388186.0 |
| Oct 02, 2024 | 40.13 | 41.11 | 39.74 | 40.84 | 381518.0 |
| Oct 01, 2024 | 40.50 | 41.02 | 39.31 | 40.38 | 584978.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
8.08
Minimum
Mar 18 2020
50.04
Maximum
Feb 09 2024
28.21
Average
31.42
Median
Mar 03 2022
Price Benchmarks
| Grace Therapeutics Inc | 3.08 |
| Aurinia Pharmaceuticals Inc | 7.315 |
| Edesa Biotech Inc | 2.66 |
| Lexaria Bioscience Corp | 2.24 |
| ESSA Pharma Inc | 1.71 |
Price Related Metrics
| PS Ratio | 239.64 |
| PEG Ratio | -1.132 |
| Price to Book Value | 3.891 |
| Earnings Yield | -6.32% |
| Market Cap | 3.284B |
| PEGY Ratio | -1.132 |